Purchases and Sales Made in Q1 2023 in Keros Therapeutics, Inc. (KROS)
This table provides information about the institutional ownership of Keros Therapeutics, Inc. (KROS) during Q1 2023. The information is specifically focused on institutions that hold shares of Keros Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 11, 2023
Q1 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-83.6K- 57.3% |
$3.46M - $4.96M
|
62.3K
$986K
|
|
|
May 11, 2023
Q1 2023
|
Citigroup Inc
|
SELL
|
- |
-86K- 20.88% |
$3.57M - $5.1M
|
326K
$5.16M
|
|
|
May 15, 2023
Q1 2023
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-111K- 47.53% |
$4.59M - $6.57M
|
122K
$1.94M
|
|
|
May 15, 2023
Q1 2023
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-129K- 81.03% |
$5.33M - $7.63M
|
30.1K
$477K
|
|
|
May 15, 2023
Q1 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-157K- 86.55% |
$6.5M - $9.31M
|
24.4K
$386K
|
|
|
May 15, 2023
Q1 2023
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-315K- 60.49% |
$13M - $18.7M
|
206K
$3.26M
|
|
|
May 15, 2023
Q1 2023
|
Darwin Global Management, Ltd.
St. Helier, Y9 |
SELL
|
- |
-397K- 92.68% |
$16.5M - $23.6M
|
31.4K
$497K
|